4 Results for: created: (02/2018 to 02/2018)

People

  1. Aghajanian
    Aghajanian
  2. Hichenberg
    Hichenberg
  3. Jhanwar
    Jhanwar
  4. Konner
    Konner
  5. Li
    Li
  6. McDonnell
    McDonnell
  7. Merghoub
    Merghoub
  8. Ozga
    Ozga
  9. Park
    Park
  10. Ricca
    Ricca

Groups

  1. Department of Medicine (4)
  2. GDMT, Medicine (4)
  3. Gynecologic Medicine Service (4)
  4. Gynecology Disease Management Team (4)
  5. Solid Tumor Oncology Division (4)
  6. Department of Pathology and Laboratory Medicine (1)
  7. GDMT, Pathology and Laboratory Medicine (1)
  8. GDMT, Surgery (1)
  9. GSK Faculty (1)
  10. MSK Library (1)
  1. "Carol Aghajanian"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
Groups
  1. Department of Medicine (4)
  2. GDMT, Medicine (4)
  3. Gynecologic Medicine Service (4)
  4. Gynecology Disease Management Team (4)
  5. Solid Tumor Oncology Division (4)
  6. Department of Pathology and Laboratory Medicine (1)

More Groups

People
  1. Carol Aghajanian (4)
  2. Alexandra Snyder Charen (1)
  3. Dmitriy Zamarin (1)
  4. Evis Sala (1)
  5. Glynnis McDonnell (1)
  6. Harini Veeraraghavan (1)

More People

Years
  1. 2017 (3)
  2. 2015 (1)
Publications
  1. International Journal of Gynecological Cancer (2)
  2. Cancer Immunology Research (1)
  3. Palliative and Supportive Care (1)
Publishers
  1. Lippincott Williams & Wilkins (2)
  2. American Association for Cancer Research (1)
  3. Cambridge University Press (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ariel3: Phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC)
    Meeting Abstract

    Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A.; Scambia, G.; more...
    International Journal of Gynecological Cancer (2017)

    Fulltext@MSK | Save
  • Baseline serum protein levels associated with survival in axalimogene filolisbac (AXAL)-treated metastatic cervical cancer patients: The GOG/NRG-0265 trial
    Meeting Abstract

    Hayes, S. M.; Petit, R. G.; Balli, D.; Hong, Q.; Huh, W.; Brady, W. E.; Dizon, D.; Powell, M. A.; Leath, C. A. 3rd; Landrum, L. M.; more...
    International Journal of Gynecological Cancer (2017)

    Fulltext@MSK | Save
  • Heterogeneous fates of metastatic lesions linked to immune escape in an ovarian cancer patient
    Meeting Abstract

    Jiménez-Sánchez, A.; Veeraraghavan, H.; Li, Y.; Vargas, H. A.; Gill, M. B.; Park, K. J.; Zivanovic, O.; Konner, J.; Ricca, J.; Zamarin, D.; more...
    Cancer Immunology Research (2017)

    Fulltext@MSK | Save
  • A systematic review of ovarian cancer and fear of recurrence
    Journal Article

    Ozga, M.; Aghajanian, C.; Myers-Virtue, S.; McDonnell, G.; Jhanwar, S.; Hichenberg, S.; Sulimanoff, I.
    Palliative and Supportive Care (2015)

    Fulltext@MSK | Save